Kalkine has a fully transformed New Avatar.
BCI Details
Significant Upgrade in FY17 EBITDA Guidance: BC Iron Ltd (ASX: BCI) recently announced for third consecutive quarter of record results from Iron Valley (operated by Mineral Resources under an ore purchase agreement with BCI). The EBITDA of A$8.1 million was reported for the December quarter 2016 from shipments of 2.1 million wet metric tonnes (wmt). The EBITDA includes positive adjustment of A$0.8 million relating to finalisation of pricing for shipments of prior periods. Further, the first half FY17 EBITDA from Iron Valley is reported to be A$12.8 million (unaudited) from shipments of 4.2 million wmt. The result was primarily driven by iron ore pricing and robust operational performance. Accordingly, the group has revised the FY17 Iron Valley EBITDA guidance to A$18 – A$25 million against the earlier provided guidance of A$6 – A$16 million.
Iron Valley Quarterly Shipments and EBITDA (Source: Company Reports)
FY16 Performance: The group reported revenue of A$151M in FY16 while net loss after tax was of the order of A$80M and underlying net loss after tax of A$9M. To manage balance sheet, the group had undertaken steps on settlement of Watpac litigation to reduce risk and suspended Nullagine (sold 75% interest to Fortescue Metals Group for an ongoing royalty). BCI had reported shipping of 6.5M wmt for BCI EBITDA of A$10.2M from Iron Valley. The group also could successfully complete $25.5M entitlement offer in FY16. Overall, BCI’s pipeline of operating assets, royalties, development projects and exploration targets indicate for an upside.
Stock Performance: The stock rallied 20% on January 12, 2017 and surged 27% in last six months (as on January 11, 2017). We give a ‘Hold’ recommendation on the stock at the current price of $ 0.21
BCI Daily Chart (Source: Thomson Reuters)
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in: BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.